Liver Cirrhosis Recruiting Phase 4 Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02190357Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled TrialTreatment